-
EP3220891
European procedure
Extract from the Register of European Patents
EP About this file: EP3220891
| EP3220891 - SUBLINGUAL FORMULATION OF RILUZOLE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.07.2020 Database last updated on 09.04.2026 | |
| Former | The patent has been granted Status updated on 21.06.2019 | ||
| Former | Grant of patent is intended Status updated on 11.02.2019 | ||
| Former | Examination is in progress Status updated on 18.05.2018 | ||
| Former | Request for examination was made Status updated on 25.08.2017 | ||
| Former | The international publication has been made Status updated on 01.11.2016 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Biohaven Therapeutics Ltd. 215 Church Street New Haven, CT 06510 / US | [2019/48] |
| Former [2017/39] | For all designated states Biohaven Pharmaceutical Holding Company Ltd. 234 Church Street Suite 301 New Haven, CT 06520 / US | Inventor(s) | 01 /
CORIC, Vladimir 7 Richborough Road Madison, CT 06443 / US | 02 /
BERMAN, Robert, M. 77 Livingston Street New Haven, CT 06511 / US | 03 /
VLADYKA, Ronald, Samuel 15 Norfolk Road Somerst, NJ 08873 / US | 04 /
SALEH, Amgad K7 Quincy Circle Dayton, NJ 08810 / US | 05 /
YU, Danny P.O. Box 1015 Somerville, MA 08876 / US | [2017/39] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2017/39] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 15823415.3 | 17.11.2015 | [2017/39] | WO2015US61114 | Priority number, date | US201462083094P | 21.11.2014 Original published format: US 201462083094 P | [2017/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016081472 | Date: | 26.05.2016 | Language: | EN | [2016/21] | Type: | A1 Application with search report | No.: | EP3220891 | Date: | 27.09.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.05.2016 takes the place of the publication of the European patent application. | [2017/39] | Type: | B1 Patent specification | No.: | EP3220891 | Date: | 24.07.2019 | Language: | EN | [2019/30] | Search report(s) | International search report - published on: | EP | 26.05.2016 | Classification | IPC: | A61K9/00, A61K9/08, A61K9/20, A61K31/428 | [2017/39] | CPC: |
A61K9/006 (EP,CN,IL,KR,US);
A61K9/0056 (EP,CN,IL,US);
A61K31/428 (EP,CN,IL,KR,US);
A61K47/20 (EP,IL,KR,US);
A61K47/26 (EP,IL,KR,US);
A61K9/08 (EP,CN,IL,US);
A61K9/19 (IL,KR);
A61K9/20 (EP,CN,IL,US);
A61P1/02 (IL,KR);
A61P25/00 (EP,IL,KR,US);
A61P25/16 (EP,IL,US);
A61P25/18 (EP,IL,US);
A61P25/22 (EP,IL,US);
A61P25/24 (EP,IL,US);
A61P25/28 (EP,IL,US);
A61P25/30 (EP,IL,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/39] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | SUBLINGUALE FORMULIERUNG VON RILUZOL | [2017/39] | English: | SUBLINGUAL FORMULATION OF RILUZOLE | [2017/39] | French: | FORMULATION SUBLINGUALE DE RILUZOLE | [2017/39] | Entry into regional phase | 19.06.2017 | National basic fee paid | 19.06.2017 | Designation fee(s) paid | 20.06.2017 | Examination fee paid | Examination procedure | 21.09.2016 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 19.06.2017 | Date on which the examining division has become responsible | 20.06.2017 | Examination requested [2017/39] | 15.12.2017 | Amendment by applicant (claims and/or description) | 23.05.2018 | Despatch of a communication from the examining division (Time limit: M04) | 01.10.2018 | Reply to a communication from the examining division | 12.02.2019 | Communication of intention to grant the patent | 14.06.2019 | Fee for grant paid | 14.06.2019 | Fee for publishing/printing paid | 14.06.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19186196.2 / EP3616686 | EP21169884.0 / EP4039247 | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/33] | Fees paid | Renewal fee | 13.11.2017 | Renewal fee patent year 03 | 14.11.2018 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MK | 24.07.2019 | SM | 24.07.2019 | IS | 24.11.2019 | [2022/31] |
| Former [2020/36] | SM | 24.07.2019 | |
| IS | 24.11.2019 | ||
| Former [2020/28] | SM | 24.07.2019 | |
| IS | 24.02.2020 | ||
| Former [2020/24] | IS | 24.02.2020 | |
| Former [2020/14] | IS | 24.11.2019 | Cited in | International search | [X] US4370338 (MIZOULE JACQUES et al.) | [XI] WO2013010015 (CYTOKINETICS INC et al.) | [XP] US2014371277 (COHEN DANIEL et al.) | [XI] CA2864008 (PHARNEXT et al.) | [X] EP2228054 (ITALFARMACO SPA et al.) | by applicant | US5631023 | US5837287 | US6149938 | US6212791 | US6284270 | US6316029 | US6465010 | US6471992 | US6509040 | US6814978 | US6908626 | US6982251 | US7282217 | US7425341 | US7939105 | US7993674 | US8048449 | US8127516 | US8158152 | US8221480 | US8256233 | US8313768 | ROWE ET AL.,: "Handbook Of Pharmaceutical Excipients fifth edition,", 2005, MCGRAW HILL |